Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease.
Cafiero C, Re A, Micera A, Palmirotta R, Monaco D, Romano F, Fabrizio C, Di Francia R, Cacciamani A, Surico PL, D'Amato G, Pisconti S. Cafiero C, et al. Among authors: fabrizio c. Pharmgenomics Pers Med. 2020 Oct 13;13:463-484. doi: 10.2147/PGPM.S270069. eCollection 2020. Pharmgenomics Pers Med. 2020. PMID: 33116761 Free PMC article. Review.
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study.
Bruno G, Saracino A, Fabrizio C, Scudeller L, Milano E, Dell'Acqua R, Ladisa N, Fasano M, Minniti S, Buccoliero G, Tartaglia A, Giammario A, Milella M, Angarano G. Bruno G, et al. Among authors: fabrizio c. Int J Antimicrob Agents. 2017 Mar;49(3):296-301. doi: 10.1016/j.ijantimicag.2016.11.030. Epub 2017 Feb 2. Int J Antimicrob Agents. 2017. PMID: 28163136
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study.
Ippolito AM, Milella M, Messina V, Conti F, Cozzolongo R, Morisco F, Brancaccio G, Barone M, Santantonio T, Masetti C, Tundo P, Smedile A, Carretta V, Gatti P, Termite AP, Valvano MR, Bruno G, Fabrizio C, Andreone P, Zappimbulso M, Gaeta GB, Napoli N, Fontanella L, Lauletta G, Cuccorese G, Metrangolo A, Francavilla R, Ciracì E, Rizzo S, Andriulli A. Ippolito AM, et al. Among authors: fabrizio c. Dig Liver Dis. 2017 Sep;49(9):1022-1028. doi: 10.1016/j.dld.2017.03.025. Epub 2017 Apr 8. Dig Liver Dis. 2017. PMID: 28487083 Free article.
The elderly and direct antiviral agents: Constraint or challenge?
Fabrizio C, Saracino A, Scudeller L, Milano E, Dell'Acqua R, Bruno G, Lo Caputo S, Monno L, Milella M, Angarano G. Fabrizio C, et al. Dig Liver Dis. 2017 Sep;49(9):1036-1042. doi: 10.1016/j.dld.2017.05.019. Epub 2017 Jun 1. Dig Liver Dis. 2017. PMID: 28651903
Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study.
Bavaro DF, Diella L, Fabrizio C, Sulpasso R, Bottalico IF, Calamo A, Santoro CR, Brindicci G, Bruno G, Mastroianni A, Buccoliero GB, Carbonara S, Lo Caputo S, Santantonio T, Monno L, Angarano G, Saracino A. Bavaro DF, et al. Among authors: fabrizio c. Int J Infect Dis. 2021 Apr;105:709-715. doi: 10.1016/j.ijid.2021.03.021. Epub 2021 Mar 17. Int J Infect Dis. 2021. PMID: 33722685 Free PMC article.
104 results